YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558) has released an update.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced its first extraordinary general meeting for 2024, to be held on October 31st, at which they will seek approval for revised annual caps on various agreements, including leasing, services, and energy purchases, as well as amendments to the company’s articles of association. The meeting will provide an opportunity for shareholders to voice their opinions on significant financial decisions that could impact the company’s operations and governance.
For further insights into HK:1558 stock, check out TipRanks’ Stock Analysis page.